
### [NCIT:C27909](http://purl.obolibrary.org/obo/NCIT_C27909)
**Label:** Mature T-Cell and NK-Cell Neoplasm

**Subclasses:** [NCIT:C4752](http://purl.obolibrary.org/obo/NCIT_C4752) (T-Cell Prolymphocytic Leukemia), [NCIT:C8678](http://purl.obolibrary.org/obo/NCIT_C8678) (Stage III Angioimmunoblastic T-cell Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C8679](http://purl.obolibrary.org/obo/NCIT_C8679) (Stage IV Angioimmunoblastic T-cell Lymphoma), [NCIT:C8676](http://purl.obolibrary.org/obo/NCIT_C8676) (Recurrent Angioimmunoblastic T-cell Lymphoma), [NCIT:C45366](http://purl.obolibrary.org/obo/NCIT_C45366) (Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder), [NCIT:C8677](http://purl.obolibrary.org/obo/NCIT_C8677) (Stage II Angioimmunoblastic T-cell Lymphoma), [NCIT:C139288](http://purl.obolibrary.org/obo/NCIT_C139288) (Node-Based EBV-Positive Peripheral T-Cell Lymphoma), [NCIT:C8674](http://purl.obolibrary.org/obo/NCIT_C8674) (Stage III Nasal Type NK/T-Cell Lymphoma), [NCIT:C5322](http://purl.obolibrary.org/obo/NCIT_C5322) (Central Nervous System Anaplastic Large Cell Lymphoma), [NCIT:C8675](http://purl.obolibrary.org/obo/NCIT_C8675) (Stage IV Nasal Type NK/T-Cell Lymphoma), [NCIT:C8672](http://purl.obolibrary.org/obo/NCIT_C8672) (Stage I Angioimmunoblastic T-cell Lymphoma), [NCIT:C8673](http://purl.obolibrary.org/obo/NCIT_C8673) (Stage II Nasal Type NK/T-Cell Lymphoma), [NCIT:C27897](http://purl.obolibrary.org/obo/NCIT_C27897) (T-Cell Proliferation of Uncertain Malignant Potential), [NCIT:C8670](http://purl.obolibrary.org/obo/NCIT_C8670) (Stage I Nasal Type NK/T-Cell Lymphoma), [NCIT:C8671](http://purl.obolibrary.org/obo/NCIT_C8671) (Refractory Angioimmunoblastic T-cell Lymphoma), [NCIT:C8680](http://purl.obolibrary.org/obo/NCIT_C8680) (Recurrent Enteropathy-Associated T-Cell Lymphoma), [NCIT:C7195](http://purl.obolibrary.org/obo/NCIT_C7195) (Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C9250](http://purl.obolibrary.org/obo/NCIT_C9250) (Recurrent Anaplastic Large Cell Lymphoma), [NCIT:C35794](http://purl.obolibrary.org/obo/NCIT_C35794) (Pagetoid Reticulosis), [NCIT:C129599](http://purl.obolibrary.org/obo/NCIT_C129599) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C129598](http://purl.obolibrary.org/obo/NCIT_C129598) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C27366](http://purl.obolibrary.org/obo/NCIT_C27366) (Adult Systemic Anaplastic Large Cell Lymphoma), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C45250](http://purl.obolibrary.org/obo/NCIT_C45250) (Cutaneous Mature T-Cell and NK-Cell Neoplasm), [NCIT:C27367](http://purl.obolibrary.org/obo/NCIT_C27367) (Adult Anaplastic Large Cell Lymphoma), [NCIT:C8689](http://purl.obolibrary.org/obo/NCIT_C8689) (Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C8688](http://purl.obolibrary.org/obo/NCIT_C8688) (Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C8685](http://purl.obolibrary.org/obo/NCIT_C8685) (Stage IV Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), [NCIT:C7197](http://purl.obolibrary.org/obo/NCIT_C7197) (Type A Lymphomatoid Papulosis), [NCIT:C8683](http://purl.obolibrary.org/obo/NCIT_C8683) (Stage II Enteropathy-Associated T-Cell Lymphoma), [NCIT:C7196](http://purl.obolibrary.org/obo/NCIT_C7196) (Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C8684](http://purl.obolibrary.org/obo/NCIT_C8684) (Stage III Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8681](http://purl.obolibrary.org/obo/NCIT_C8681) (Refractory Enteropathy-Associated T-Cell Lymphoma), [NCIT:C7199](http://purl.obolibrary.org/obo/NCIT_C7199) (Type C Lymphomatoid Papulosis), [NCIT:C7198](http://purl.obolibrary.org/obo/NCIT_C7198) (Type B Lymphomatoid Papulosis), [NCIT:C8682](http://purl.obolibrary.org/obo/NCIT_C8682) (Stage I Enteropathy-Associated T-Cell Lymphoma), [NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta), [NCIT:C8690](http://purl.obolibrary.org/obo/NCIT_C8690) (Stage I Mature T- and NK-Cell Lymphoma), [NCIT:C8691](http://purl.obolibrary.org/obo/NCIT_C8691) (Stage II Mature T- and NK-Cell Lymphoma), [NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant), [NCIT:C3246](http://purl.obolibrary.org/obo/NCIT_C3246) (Mycosis Fungoides), [NCIT:C8938](http://purl.obolibrary.org/obo/NCIT_C8938) (Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C7208](http://purl.obolibrary.org/obo/NCIT_C7208) (Small Cell Variant Anaplastic Large Cell Lymphoma), [NCIT:C3366](http://purl.obolibrary.org/obo/NCIT_C3366) (Sezary Syndrome), [NCIT:C7205](http://purl.obolibrary.org/obo/NCIT_C7205) (Lymphoepithelioid Variant Peripheral T-Cell Lymphoma), [NCIT:C5026](http://purl.obolibrary.org/obo/NCIT_C5026) (Recurrent Nasal Type NK/T-Cell Lymphoma), [NCIT:C45340](http://purl.obolibrary.org/obo/NCIT_C45340) (Primary Cutaneous Gamma-Delta T-Cell Lymphoma), [NCIT:C8658](http://purl.obolibrary.org/obo/NCIT_C8658) (Refractory Anaplastic Large Cell Lymphoma), [NCIT:C96058](http://purl.obolibrary.org/obo/NCIT_C96058) (Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma), [NCIT:C7204](http://purl.obolibrary.org/obo/NCIT_C7204) (T-Zone Variant Peripheral T-Cell Lymphoma), [NCIT:C8659](http://purl.obolibrary.org/obo/NCIT_C8659) (Stage I Anaplastic Large Cell Lymphoma), [NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C37196](http://purl.obolibrary.org/obo/NCIT_C37196) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C37195](http://purl.obolibrary.org/obo/NCIT_C37195) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C9470](http://purl.obolibrary.org/obo/NCIT_C9470) (Systemic Anaplastic Large Cell Lymphoma), [NCIT:C68692](http://purl.obolibrary.org/obo/NCIT_C68692) (Childhood Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C4737](http://purl.obolibrary.org/obo/NCIT_C4737) (Enteropathy-Associated T-Cell Lymphoma), [NCIT:C6918](http://purl.obolibrary.org/obo/NCIT_C6918) (Subcutaneous Panniculitis-Like T-Cell Lymphoma), [NCIT:C8669](http://purl.obolibrary.org/obo/NCIT_C8669) (Refractory Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C4340](http://purl.obolibrary.org/obo/NCIT_C4340) (Peripheral T-Cell Lymphoma, Not Otherwise Specified), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C37194](http://purl.obolibrary.org/obo/NCIT_C37194) (Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C8661](http://purl.obolibrary.org/obo/NCIT_C8661) (Stage III Anaplastic Large Cell Lymphoma), [NCIT:C37193](http://purl.obolibrary.org/obo/NCIT_C37193) (Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C8662](http://purl.obolibrary.org/obo/NCIT_C8662) (Stage IV Anaplastic Large Cell Lymphoma), [NCIT:C7298](http://purl.obolibrary.org/obo/NCIT_C7298) (Splenic Manifestation of T-Cell Prolymphocytic Leukemia), [NCIT:C8660](http://purl.obolibrary.org/obo/NCIT_C8660) (Stage II Anaplastic Large Cell Lymphoma), [NCIT:C39644](http://purl.obolibrary.org/obo/NCIT_C39644) (Mycosis Fungoides Variant), [NCIT:C128697](http://purl.obolibrary.org/obo/NCIT_C128697) (NK-Cell Lymphoma, Unclassifiable), [NCIT:C128696](http://purl.obolibrary.org/obo/NCIT_C128696) (Peripheral T-Cell Lymphoma, Unclassifiable), [NCIT:C3467](http://purl.obolibrary.org/obo/NCIT_C3467) (Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C115439](http://purl.obolibrary.org/obo/NCIT_C115439) (Recurrent Mycosis Fungoides and Sezary Syndrome), [NCIT:C3468](http://purl.obolibrary.org/obo/NCIT_C3468) (Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C139005](http://purl.obolibrary.org/obo/NCIT_C139005) (Nodal Peripheral T-Cell Lymphoma), [NCIT:C7302](http://purl.obolibrary.org/obo/NCIT_C7302) (Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C115154](http://purl.obolibrary.org/obo/NCIT_C115154) (Adult Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115030](http://purl.obolibrary.org/obo/NCIT_C115030) (Stage II Childhood Anaplastic Large Cell Lymphoma), [NCIT:C45327](http://purl.obolibrary.org/obo/NCIT_C45327) (Hydroa Vacciniforme-Like Lymphoproliferative Disorder), [NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype), [NCIT:C88160](http://purl.obolibrary.org/obo/NCIT_C88160) (Stage IV Mycosis Fungoides and Sezary Syndrome), [NCIT:C8647](http://purl.obolibrary.org/obo/NCIT_C8647) (Aggressive NK-Cell Leukemia), [NCIT:C7798](http://purl.obolibrary.org/obo/NCIT_C7798) (Stage II Mycosis Fungoides), [NCIT:C9339](http://purl.obolibrary.org/obo/NCIT_C9339) (Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C45332](http://purl.obolibrary.org/obo/NCIT_C45332) (Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype), [NCIT:C4684](http://purl.obolibrary.org/obo/NCIT_C4684) (Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C45339](http://purl.obolibrary.org/obo/NCIT_C45339) (Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma), [NCIT:C88157](http://purl.obolibrary.org/obo/NCIT_C88157) (Stage III Mycosis Fungoides and Sezary Syndrome), [NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant), [NCIT:C129600](http://purl.obolibrary.org/obo/NCIT_C129600) (Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C88150](http://purl.obolibrary.org/obo/NCIT_C88150) (Stage I Mycosis Fungoides and Sezary Syndrome), [NCIT:C88153](http://purl.obolibrary.org/obo/NCIT_C88153) (Stage II Mycosis Fungoides and Sezary Syndrome), [NCIT:C3721](http://purl.obolibrary.org/obo/NCIT_C3721) (Lymphomatoid Papulosis), [NCIT:C7528](http://purl.obolibrary.org/obo/NCIT_C7528) (Angioimmunoblastic T-Cell Lymphoma), [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C7805](http://purl.obolibrary.org/obo/NCIT_C7805) (Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C8459](http://purl.obolibrary.org/obo/NCIT_C8459) (Hepatosplenic T-Cell Lymphoma), [NCIT:C3720](http://purl.obolibrary.org/obo/NCIT_C3720) (Anaplastic Large Cell Lymphoma), [NCIT:C45268](http://purl.obolibrary.org/obo/NCIT_C45268) (Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8692](http://purl.obolibrary.org/obo/NCIT_C8692) (Stage III Mature T- and NK-Cell Lymphoma), [NCIT:C8693](http://purl.obolibrary.org/obo/NCIT_C8693) (Stage IV Mature T- and NK-Cell Lymphoma), [NCIT:C9265](http://purl.obolibrary.org/obo/NCIT_C9265) (Mycosis Fungoides and Sezary Syndrome), [NCIT:C5636](http://purl.obolibrary.org/obo/NCIT_C5636) (Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5637](http://purl.obolibrary.org/obo/NCIT_C5637) (Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C45271](http://purl.obolibrary.org/obo/NCIT_C45271) (Cutaneous Angioimmunoblastic T-Cell Lymphoma), [NCIT:C4664](http://purl.obolibrary.org/obo/NCIT_C4664) (T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C80375](http://purl.obolibrary.org/obo/NCIT_C80375) (Follicular T-Cell Lymphoma), [NCIT:C139014](http://purl.obolibrary.org/obo/NCIT_C139014) (Type D Lymphomatoid Papulosis), [NCIT:C139015](http://purl.obolibrary.org/obo/NCIT_C139015) (Type E Lymphomatoid Papulosis), [NCIT:C139011](http://purl.obolibrary.org/obo/NCIT_C139011) (Nodal Peripheral T-Cell Lymphoma with TFH Phenotype), [NCIT:C80373](http://purl.obolibrary.org/obo/NCIT_C80373) (EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood), 

**Class expressions from DL-Learner:**

- Thing 59.54%
- [CL:0000084](http://purl.obolibrary.org/obo/CL_0000084) (T cell) 56.94%
- [CL:0002419](http://purl.obolibrary.org/obo/CL_0002419) (mature T cell) 55.11%
- [NCIT:C39568](http://purl.obolibrary.org/obo/NCIT_C39568) (Peripheral (Post-Thymic) T-Lymphocyte and Natural Killer Cell) 52.27%
- [NCIT:C38434](http://purl.obolibrary.org/obo/NCIT_C38434) (Peripheral (Post-Thymic) T-Lymphocyte) 51.70%
- [CL:0002420](http://purl.obolibrary.org/obo/CL_0002420) (immature T cell) 51.70%
- [CL:0000893](http://purl.obolibrary.org/obo/CL_0000893) (thymocyte) 51.70%
- [CL:0000084](http://purl.obolibrary.org/obo/CL_0000084) (T cell) and [NCIT:C39568](http://purl.obolibrary.org/obo/NCIT_C39568) (Peripheral (Post-Thymic) T-Lymphocyte and Natural Killer Cell) 51.70%
- [CL:0000084](http://purl.obolibrary.org/obo/CL_0000084) (T cell) and [NCIT:C39567](http://purl.obolibrary.org/obo/NCIT_C39567) (T-Lymphocyte and Natural Killer Cell) 51.70%
- [CL:0001067](http://purl.obolibrary.org/obo/CL_0001067) (group 1 innate lymphoid cell) 51.14%
- [CL:0001065](http://purl.obolibrary.org/obo/CL_0001065) (innate lymphoid cell) 51.14%
- [CL:0000911](http://purl.obolibrary.org/obo/CL_0000911) (effector T cell) 51.14%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) 51.14%
- [CL:0000798](http://purl.obolibrary.org/obo/CL_0000798) (gamma-delta T cell) 51.14%
- [CL:0000623](http://purl.obolibrary.org/obo/CL_0000623) (natural killer cell) 51.14%


